Medications

30 years on, are we winning the fight against Alzheimer's?

UC San Francisco experts say that we have reached a pivotal point in Alzheimer's disease research, 30 years after the first pharmaceutical came to market. On Jan. 6, 2023, the Food and Drug Administration is expected to give ...

Oncology & Cancer

Earlier detection of a malignancy in neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3,000 individuals, and people with NF1 are at greater risk of developing a rare, aggressive form of cancer. Diagnosing malignant peripheral nerve ...

Oncology & Cancer

Researchers develop an improved hereditary cancer test

Researchers at the BC Cancer Research Institute have made an advancement in genetic testing that allows for more accurate prediction of which parent's genes led to an individual's increased cancer risk. This improves the ...

page 15 from 40